The company was founded in 2005 and is the first listed company in the field of pathological diagnosis in China. It integrates R&D, production, marketing, service and education, and has built four major businesses: tumor screening, tumor diagnosis, digital pathology, and pathology services. The company is mainly engaged in R&D, production and sales of pathological diagnostic reagents and instruments. The main products are in vitro diagnostic reagents and diagnostic instruments. Company honors: Municipal Industrial Design Center, High-tech Enterprise, Guangzhou Clean Production Enterprise, etc.
No Data